X
  • No products in the list
Quality Controls & Reference Standards > cfDNA/ctDNA > Oncology Multiplex cfDNA

5 Gene Multiplex 1% AF cfDNA

Quality Controls & Reference Standards > cfDNA/ctDNA > Oncology Multiplex cfDNA

5 Gene Multiplex 1% AF cfDNA

Product highlights

  • Enhances performance in these advanced techniques.
  • Aids in validating sequencing and PCR protocols.
  • Facilitates precise determination of detection limits.
  • Suitable for various research and clinical settings.

5 Gene Multiplex 1% AF cfDNA

About 5 Gene Multiplex 1% AF cfDNA

Selected genes and mutations play a crucial role in diagnosis and treatment across various cancers, including breast, colorectal, melanoma, lung, prostate, and others.

The 5 Gene Multiplex 1% AF cfDNA product serves as a positive standard for liquid biopsy assays in diagnostic labs and R&D settings. It is also designed for validating and developing diagnostic kits targeting AKT1, BRAF, KRAS, ERBB2, or PIK3CA. This product is made from highly characterized human cfDNA derived from cell lines, ensuring accuracy and reliability in testing.

Specifications of the 5 Gene Multiplex 1% AF cfDNA

The selected genes and mutations are critical for both diagnosis and treatment, influencing various types of tumors, including:

– Breast cancer
– Colorectal cancer
– Melanoma
– Non-Small Cell Lung Cancer
– Small Cell Lung Cancer
– Prostate cancer
– Lymphoma
– Head and Neck Cancer
– Hepatocellular Carcinoma
– Multiple Myeloma
– Pancreatic Adenocarcinoma
– Ovarian Cancer
– Bladder Cancer
– Bile Duct Cancer

The 5-Gene-Multiplex 1% AF cfDNA product serves as a positive standard for liquid biopsy assays in diagnostic laboratories or R&D settings. It is also useful for the validation and development of diagnostic kits targeting AKT1, BRAF, KRAS, ERBB2, or PIK3CA. This product is derived from highly characterized human cfDNA sourced from cell lines, ensuring reliability and accuracy in your testing processes.

Explore newest products